Activity 1: Assist WHO in providing technical support for UHC and contribute to WHO policy for UHC

Universal health care coverage (UHC) is widely accepted as one of key goals of health system and policy. Many low- and middle-income countries (LMICs) of Asia are struggling toward UHC, but they should overcome various barriers in health systems. Korea achieved universal health coverage in a relatively short time period, and the process of achieving UHC can provide valuable lessons (both positive and negative) to LMICs in the WPRO region. The collaborating center can work with WHO in providing technical support to the member states in their efforts to achieve UHC. The technical areas cover the revenue collection, pooling and purchasing. Pharmaceutical policy is also included.

Expected deliverables: 
- Technical support to WPRO countries in developing their national health insurance system and health financing policy
- Consultancy reports on key topics of UHC; Policy briefing and recommendation note responding to the needs of specific LMICs
- Host study visits of policy makers from LMICs

Activity 2: Building country capacity on health system and financing 

The capacity in developing evidence-based policy is critical for sustainable development of health system for UHC. Taking the advantage of faculty in the university training workshops for multi-countries and individual countries will be organized. The topics will cover broader health system and health financing areas, but be tailored according countries’ need. The audience of the training will be government officials as well as policy researchers in universities and academic institutions. Apart from training courses, the SPH will also provide hand-on technical support to country team on specific technical topics. 

Expected deliverables: 
- to organize training courses on health financing, health insurance
- technical support to country team in policy research in the area of health financing 

Activity 3: Pharmaceutical policy network and regional hub

Pharmaceuticals and technology are a major component of health system and increasing equitable access to essential medicines and health technologies is a key corner stone of efforts directed at moving toward UHC. Expenditure on medicines often cause catastrophic health expenditure and often significant portion of overall healthcare costs.  National pharmaceutical policy needs to adopt a health system perspective, beyond its emphasis on safety, quality and efficacy issues and link clearly with health system financing policies to achieve most efficient use. The collaboration center will serve as a platform for experts and policy makers in the region to discuss key policy issues and generate evidence-based policy recommendations for pharmaceuticals with regard to selection, financing and use medicines and health technologies to achieve optimal outcomes with limited resources available to health systems.

Expected deliverables: 
- Series of reports on key policy issues of pharmaceutical policy, technical papers and guideline for pharmaceutical policy. 
- Participation and support to regional knowledge hub/ collaborations that can facilitate sharing of experiences and mutual learning between national policy and decision and contribute to capacity development. 

Funding sources: 
The Center will work on various projects funded by MoHW (Ministry of Health and Welfare), KOICA (Korea International Cooperation Agency), KoFIH (Korea Foundation for International Health), NHIS (National Health Insurance Service), HIRA (Health Insurance Review and Assessment) in addition to international organizations.